Athersys Inc.

0.7119-0.0104-1.44%Vol 1.88M1Y Perf -56.22%
May 18th, 2022 16:00 DELAYED
BID0.6999 ASK0.7500
Open0.7218 Previous Close0.7223
Pre-Market- After-Market0.75
 - -  0.04 5.14%
Target Price
4.00 
Analyst Rating
Moderate Buy 2.00
Potential %
461.88 
Finscreener Ranking
+ —    -
Insiders Trans % 3/6/12 mo.
100/100/-33 
Value Ranking
     23.59
Insiders Value % 3/6/12 mo.
100/100/-12 
Growth Ranking
     25.46
Insiders Shares Cnt. % 3/6/12 mo.
100/100/16 
Income Ranking
 —    -
Price Range Ratio 52W %
18.60 
Earnings Rating
Buy
Market Cap183.72M 
Earnings Date
6th May 2022
Alpha0.01 Standard Deviation0.24
Beta-1.30 

Today's Price Range

0.68000.7300

52W Range

0.46101.81

5 Year PE Ratio Range

-6.40-7.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
24.28%
1 Month
42.44%
3 Months
-15.91%
6 Months
-36.08%
1 Year
-56.22%
3 Years
-63.34%
5 Years
-49.84%
10 Years
-46.89%

TickerPriceChg.Chg.%
ATHX0.7119-0.0104-1.44
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.00
0.97
31.01
-
Leverage Ratio 3.30
ProfitabilityValueIndustryS&P 500US Markets
-
-983.20
-966.30
-2 110.40
-
RevenueValueIndustryS&P 500US Markets
8.43M
0.03
-30.02
2.51
Earnings HistoryEstimateReportedSurprise %
Q01 2022--0.09-
Q04 2021-0.07-0.09-28.57
Q03 2021-0.08-0.0712.50
Q02 2021-0.08-0.10-25.00
Q01 2021-0.08-0.13-62.50
Q04 2020-0.09-0.11-22.22
Q03 2020-0.08-0.11-37.50
Q02 2020-0.08-0.10-25.00
Earnings Per EndEstimateRevision %Trend
12/2021 QR-0.050.00-
6/2022 QR-0.09-132.14Negative
12/2022 FY0.25-87.92Negative
12/2023 FY0.85--
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.88M
Shares Outstanding258.07K
Shares Float234.40M
Trades Count6.54K
Dollar Volume1.33M
Avg. Volume2.97M
Avg. Weekly Volume2.76M
Avg. Monthly Volume3.20M
Avg. Quarterly Volume2.95M

Athersys Inc. (NASDAQ: ATHX) stock closed at 0.7223 per share at the end of the most recent trading day (a 11.45% change compared to the prior day closing price) with a volume of 2.08M shares and market capitalization of 183.72M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 83 people. Athersys Inc. CEO is William Lehmann.

The one-year performance of Athersys Inc. stock is -56.22%, while year-to-date (YTD) performance is -19.98%. ATHX stock has a five-year performance of -49.84%. Its 52-week range is between 0.461 and 1.81, which gives ATHX stock a 52-week price range ratio of 18.60%

Athersys Inc. currently has a PE ratio of -1.70, a price-to-book (PB) ratio of 478.33, a price-to-sale (PS) ratio of 19.38, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -146.07%, a ROC of -285.06% and a ROE of -449.07%. The company’s profit margin is -%, its EBITDA margin is -966.30%, and its revenue ttm is $8.43 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from Athersys Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Athersys Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Athersys Inc. is Moderate Buy (2), with a target price of $4, which is +461.88% compared to the current price. The earnings rating for Athersys Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athersys Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athersys Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 28.20, ATR14 : 0.09, CCI20 : 218.19, Chaikin Money Flow : -0.07, MACD : 0.01, Money Flow Index : 60.31, ROC : 47.38, RSI : 61.82, STOCH (14,3) : 94.43, STOCH RSI : 1.00, UO : 50.19, Williams %R : -5.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athersys Inc. in the last 12-months were: Daniel A. Camardo (Buy at a value of $102 256), Ismail Kola (Buy at a value of $81 702), Ivor Macleod (Buy at a value of $17 706), John J. Harrington (Sold 47 874 shares of value $79 682 ), William Lehmann (Option Excercise at a value of $25 600), William Lehmann (Sold 120 000 shares of value $177 168 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

Athersys Inc.

Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is a significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

CEO: William Lehmann

Telephone: +1 216 431-9900

Address: 3201 Carnegie Avenue, Cleveland 44115-2634, OH, US

Number of employees: 83

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

74%26%

Bearish Bullish

69%31%

TipRanks News for ATHX

Wed, 16 Mar 2022 16:42 GMT Athersys (ATHX) Gets a Hold Rating from Bank of America Securities

- TipRanks. All rights reserved.

Thu, 03 Feb 2022 13:10 GMT Analysts Offer Insights on Healthcare Companies: Athersys (ATHX) and Eli Lilly & Co (LLY)

- TipRanks. All rights reserved.

News

Stocktwits